SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance

Clinical trial NCT01266148 · COMPLETED

Trial details

NCT number: NCT01266148
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Renal Function and Chronic Allograft Vasculopathy

Start date: 2009-11-01
Primary completion: 2012-12-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.